申请人:Probiodrug AG
公开号:US08269019B2
公开(公告)日:2012-09-18
Novel heterocyclic derivatives as inhibitors of glutaminyl cyclase (QC, EC 2.3.2.5). QC catalyzes the intramolecular cyclization of N-terminal glutamine residues into pyroglutamic acid (5-oxo-prolyl, pGlu*) under liberation of ammonia and the intramolecular cyclization of N-terminal glutamate residues into pyroglutamic acid under liberation of water.
新型杂环衍
生物作为谷
氨酰环化酶(QC,
EC 2.3.2.5)的
抑制剂。QC催化N-末端谷
氨酰残基的分子内环化成为
吡二酰
氨基丙酸(5-氧代脯
氨酰基,pGlu *),同时释放
氨,以及N-末端谷
氨酸残基的分子内环化成为
吡二酰
氨基丙酸,同时释放
水。